women's health

News

Bottle of Qulipta superimposed on image of woman holding head against sun dappled wall

AbbVie charts a new course for CGRPs in menstrual migraine

AbbVie's Qulipta has become the first oral CGRP inhibitor to show efficacy in a phase 3 study involving women with menstrual migraine.

R&D

Clinical Trials Round-Up: May and June 2026

May and June delivered a plethora of clinical trial updates. In the build-up to ASCO in June, our inbox was overflowing with oncology trial results.

News

Bayer gets €3bn from Apollo for contraceptives unit stake

Bayer has partnered with private equity group Apollo to set up a new entity that will handle its long-acting contraceptives products.

News

NICE backs NHS use of non-invasive endometriosis tests

Women with endometriosis in England could be offered simple non-invasive tests for diagnosis of their condition, rather than a surgical procedure.

News

Two women sit side by side in support of each other, one in a white coat and beret, the other in red

NICE guidance calls for quicker diagnosis of PMOS

Women with polyendocrine metabolic ovarian syndrome (PMOS) should be diagnosed sooner and be offered an annual review, according to new NICE guidance.

Patients

Is women’s health reaching an inflection point?

A half-day symposium – titled Women’s Health: From Intractable to Investable – was held in London on 11th June, organised by Weatherden.

AbbVie charts a new course for CGRPs in menstrual migraine

Clinical Trials Round-Up: May and June 2026

Bayer gets €3bn from Apollo for contraceptives unit stake

NICE backs NHS use of non-invasive endometriosis tests

NICE guidance calls for quicker diagnosis of PMOS

Is women’s health reaching an inflection point?

argenx's Forte acquisition delivers coeliac trial win

Discover a new era of healthcare panel engagement: Grounded ...

women's health

Editor's Picks